Business article - June 13, 2019
Interview: Spago Nanomedical – Aiming to improve cancer care
The company recently reached an important milestone with its contrast agent SpagoPix and, if the results are positive, it could enhance cancer care. Spago Nanomedical was founded in 2007 as a subsidiary of Accelerator Nordic. The purpose was to advance an invention from the University of Linköping regarding the use of gadolinium-based nanoparticles as a […]
Business article - May 28, 2019
Hey there, Alex Haahr Gouliaev
Nordic Life Science asked the CEO of Nuevolution about the offer from Amgen to buy Nuevolution for $166.8 million. Nuevolution’s pipeline and selective deal-making approach has recently proven to be both solid and successful, with presentations of progress in multiple projects, and last week, Amgen made an offer. What’s your comment about the Amgen offer? “The […]
Business article - May 20, 2019
Carina Schmidt among top 20 women in leading biotech roles in Europe
Labiotech.eu has chosen to highlight 20 women they think are making an impact in the European biotech industry, and among them is Carina Schmidt, the CEO of Athera Biotechnologies. Like many technological fields, people with leading roles in big biotech companies have been predominantly male. Nowadays, female representation in biotech leadership roles is slowly increasing, and […]
Business article - April 15, 2019
Business Q&A: Herantis Pharma
We asked the CEO of Herantis Pharma, Pekka Simula, about what is in their pipeline right now, about their strategy to reach market and about patient-driven innovation. Herantis Pharma was created by a merger of two pharma companies, Hermo Pharma and Laurantis Pharma. It has a broad product portfolio in various therapeutic areas and several […]
Business article - April 3, 2019
Umeå Biotech Incubator enters a new development phase
Umeå Biotech Incubator (UBI) aims to double the number of small and medium-sized life science companies operating in the Västerbotten county over the next ten years. “We have finally reached the incubator phase that I have been looking forward to for so long,” said Jennie Ekbeck, CEO of Umeå Biotech Incubator. “The life science companies that […]
Business article - March 6, 2019
Company in focus: Modus Therapeutics
Swedish drug development company Modus Therapeutics has had a busy year, and 2019 could take them one step closer to having sevuparin on the market. In 2016 the clinical-stage drug development and Karolinska Development portfolio company Dilaforette Holding changed its name to Modus Therapeutics Holding. The move signified the company’s emancipation from its parent company […]
